Carsten Thiel is now a member of the EUSA Pharma. The firm deals with biopharmaceuticals. Their main focus is on rare diseases and oncology. They brought Carsten Thiel on board in a bid to solidify the corporation’s leadership. Carsten Thiel will serve as the president, and he will be in charge of the company’s operations in Europe. The experience that he bears regarding pharmaceuticals will help in enhancing the growth of the commercial infrastructure within Europe.
Experience is important, especially when an individual is set to occupy an executive position within a company. As for Carsten Thiel, he has more than 27 years’ experience in the pharmaceutical sector. He has also held different international roles during this period. Since he has also served in positions such as being a CEO, Carsten Thiel will have an easy time serving as a President to the EUSA Europe. He also has some experience when it comes to dealing with oncology in the European region.
EUSA Pharma was founded in the year 2015. The company operates internationally. At the moment, they have a base of operation in the U.S. and Europe. The management team at EUSA Pharma is also experienced, and their track record is admirable.
Since Carsten Thiel was born and raised in Berlin, Germany, being appointed as the President of EUSA Pharma Europe was a wise move. He also studied Chemistry. Since he admired the Anglo-Saxon system of education, he enrolled at the University of Bristol in the United Kingdom. He undertook organic chemistry. Carsten Thiel then went ahead to major in biochemistry. After that, he enrolled for a Ph.D. in Molecular Biology. His main focus was on the proteins that are involved in the formation of cancerous cells. After completing his studies, he ventured into the pharmaceuticals industry. He got his first job at Hoffman La-Roche, a firm that deals with biotechnology. Throughout his career, he has always adhered to the code of ethics, and it has been an admirable trait.
Details Carsten On Facebook : https://www.facebook.com/carsten.thiel.58